Chronic Lymphocytic Leukemia (CLL) Archives - Insights https://news.mayocliniclabs.com/category/hematology/lymphoma/chronic-lymphocytic-leukemia-cll/ Get the latest news and education from Mayo Clinic Laboratories Fri, 10 May 2024 15:21:46 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.1 Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros https://news.mayocliniclabs.com/2023/12/11/specialized-testing-helps-reverse-effects-of-stiff-person-syndrome-james-kypuros/ https://news.mayocliniclabs.com/2023/12/11/specialized-testing-helps-reverse-effects-of-stiff-person-syndrome-james-kypuros/#respond Mon, 11 Dec 2023 14:00:00 +0000 https://news.mayocliniclabs.com/?p=106916 Specialized testing helps reverse effects of stiff-person syndrome: James KypurosOne summer morning, James Kypuros awoke to find his toes stiffened like claws. Then he started having falls, which culminated in losing his ability to walk or even sit up without help. Diagnosed with stiff-person syndrome, James wouldn’t find hope or relief until he was treated for glycine receptor antibody syndrome following specialized testing by Mayo Clinic.

The post Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/12/11/specialized-testing-helps-reverse-effects-of-stiff-person-syndrome-james-kypuros/feed/ 0 IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll/ https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll/#respond Mon, 12 Aug 2019 12:30:01 +0000 https://news.mayocliniclabs.com/?p=53459 <em>IGHV</em> and <em>TP53</em> Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL)In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53 sequencing in these patients.

The post <em>IGHV</em> and <em>TP53</em> Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) appeared first on Insights.

]]> https://news.mayocliniclabs.com/2019/08/12/ighv-and-tp53-sequencing-clinical-utility-in-chronic-lymphocytic-leukemia-cll/feed/ 0 Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic Leukemia https://news.mayocliniclabs.com/2019/06/06/curtis-hanson-m-d-discusses-prognostic-markers-for-chronic-lymphocytic-leukemia/ https://news.mayocliniclabs.com/2019/06/06/curtis-hanson-m-d-discusses-prognostic-markers-for-chronic-lymphocytic-leukemia/#respond Thu, 06 Jun 2019 18:30:30 +0000 https://news.mayocliniclabs.com/?p=52148 Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic LeukemiaCurtis Hanson, M.D., discusses the importance of detecting immunoglobulin heavy-chain variable region gene (IGHV) when acquiring prognostic and potentially therapeutic information in chronic lymphocytic leukemia (CLL) patients in CAP TODAY.

The post Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic Leukemia appeared first on Insights.

]]> https://news.mayocliniclabs.com/2019/06/06/curtis-hanson-m-d-discusses-prognostic-markers-for-chronic-lymphocytic-leukemia/feed/ 0